[HTML][HTML] Outpatient monitoring of patients with multisystem inflammatory syndrome (MIS-C): a mini review

JT Jose, ES Selamet Tierney - Frontiers in Pediatrics, 2022 - frontiersin.org
Introduction As we learn more about the novel multisystem inflammatory syndrome in
children (MIS-C) associated with COVID-19 infection, the protocols for long-term follow-up …

[HTML][HTML] Multisystem inflammatory syndrome in children and SARS-CoV-2: A scoping review

N Panigrahy, J Policarpio… - Journal of Pediatric …, 2020 - content.iospress.com
PURPOSE: The pandemic caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has infected over 43 million people resulting in over 1 million deaths …

[HTML][HTML] Emerging evidence on multisystem inflammatory syndrome in children associated with SARS-CoV-2 infection: a systematic review with meta-analysis

M Sood, S Sharma, I Sood, K Sharma… - SN comprehensive clinical …, 2021 - Springer
With the increased spread of severe acute respiratory syndrome coronavirus 2 infection,
more patients with multisystem inflammatory syndrome in children (MIS-C) are being …

Pathogenesis, immunology, and immune‐targeted management of the multisystem inflammatory syndrome in children (MIS‐C) or pediatric inflammatory multisystem …

W Feleszko, M Okarska‐Napierała… - Pediatric Allergy and …, 2023 - Wiley Online Library
Multisystem inflammatory syndrome in children (MIS‐C) is a rare, but severe complication of
coronavirus disease 2019 (COVID‐19). It develops approximately 4 weeks after severe …

[HTML][HTML] Multicenter randomized trial of methylprednisolone vs. Intravenous immunoglobulins to treat the pediatric inflammatory multisystem syndrome—temporally …

T Welzel, N Schöbi, MC André, DGN Bailey… - Frontiers in …, 2022 - frontiersin.org
Introduction In 2020, a new disease entitled Pediatric Inflammatory Multisystem Syndrome
temporally associated with COVID-19 (PIMS-TS), or Multisystem Inflammatory Syndrome in …

[HTML][HTML] Treatments for multi-system inflammatory syndrome in children—discharge, fever, and second-line therapies

A Tagarro, S Domínguez-Rodríguez, JM Mesa… - European journal of …, 2023 - Springer
Scarce evidence exists about the best treatment for multi-system inflammatory syndrome
(MIS-C). We analyzed the effects of steroids, intravenous immunoglobulin (IVIG), and their …

Recent experience: corticosteroids as a first-line therapy in children with multisystem inflammatory syndrome and COVID-19-related myocardial damage

V Vukomanovic, S Krasic, S Prijic, S Ninic… - The Pediatric …, 2021 - journals.lww.com
Background: Cardiovascular complications with myocarditis in multisystem inflammatory
syndrome in children (MIS-C) associated with severe acute respiratory syndrome …

[HTML][HTML] Clinical practice guidelines in multisystem inflammatory syndrome (MIS-C) related to COVID-19: a critical review and recommendations

AS Algarni, NM Alamri, NZ Khayat, RA Alabdali… - World Journal of …, 2022 - Springer
Background Multisystem inflammatory syndrome in children (MIS-C) is a serious health
condition that develops from and is linked to coronavirus disease 2019. MIS-C is considered …

[HTML][HTML] Cardiac dysfunction in multisystem inflammatory syndrome in children: an Italian single-center study

S Mannarino, I Raso, M Garbin, E Ghidoni… - Italian Journal of …, 2022 - Springer
Background Multisystem inflammatory syndrome in children (MIS-C) is a novel condition
temporally associated with SARS-CoV2 infection. Cardiovascular involvement is mainly …

Multisystem Inflammatory Syndrome in Children: Two Years' Worth of Learning

SMK Alexander, JB Lykes, C Nassef… - Clinical …, 2024 - journals.sagepub.com
Multisystem inflammatory syndrome in children (MIS-C) is a life-threatening sequela of
SARS-CoV-2 infection. Limited data are available regarding risk-stratification or long-term …